Virotech   Report issue

For profit Phase 1
Founded: Guangzhou China (2015)

Organization Overview

First Clinical Trial
2020
NCT04665362
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Guangzhou Virotech Pharmaceutical Co., Ltd.